I am a Health Services Research and Health Policy PhD student in the health economics track at Emory University. I am interested in Medicare policy, and the affordability and accessibility of prescription drugs and other medical products. My current research focus is access to high-cost medications for type 2 diabetes in Medicare.
I previously worked with the Duke University Margolis Center for Health Policy with a focus on coverage, payment, and competition issues around biologic drugs and cell and gene therapy.
Areas of Interest
- Chronic Diseases
- Health Disparities
- Health Economics
- Health Policy
- Health Services Research
Education
- B.A. 2019, Swarthmore College
Publications
- Nitzan Arad, Elizabeth Staton, Marianne Hamilton Lopez, Mark McClellan, 2023, Alzheimer’s Disease Monoclonal Antibodies with Traditional Approval: Clarifying the Pathway for Medicare Postmarket Evidence Development and Use, Duke-Margolis, (Policy Brief),
- Mark McClellan, Marianne Hamilton Lopez, Beena Bhuiyan Kahn, Nitzan Arad, Elizabeth Staton, Hannah Graunke, 2022, Medicare Coverage of Monoclonal Antibody Treatments for Alzheimer’s Disease: Key Issues from the CMS Proposed Coverage Decision, Duke-Margolis, (Policy brief),
- Nitzan Arad, Elizabeth Staton, Marianne Hamilton Lopez, Samson Goriola, Aparna Higgins, Mark McClellan, Barak Richman, 2022, Realizing the Benefits of Biosimilars: Overcoming Rebate Walls, Duke-Margolis and The Commonwealth Fund, (White paper),